Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Robert Birch

Orthopaedic Surgery Coral Gables, FL Medical Doctor

NPI 1750885091 CMS profile 11462947

1150 Campo Sano Avenue, 2Nd Fl, Baptist Health Orthopedic Care, Coral Gables, FL 33146

Open in the dashboard

General payments

$11,358

58 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Birch of Coral Gables, FL is reported in the CMS Open Payments database as having received $11,358 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $651 12
2024 General $6,306 34
2023 General $4,401 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Birch
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Robert Birch were reported at $651. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Robert Birch Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $0 $520 $117–$2,495 $132
2022 $0 $598 $128–$2,731 $149
2023 $4,401 $461 $128–$2,264 $160
2024 $6,306 $497 $134–$2,475 $164
2025 $651 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Smith+Nephew, Inc. $6,000 2 payments
  2. Stryker Corporation $2,562 25 payments
  3. Medical Device Business Services, Inc. $1,212 6 payments
  4. Zimmer Biomet Holdings, Inc. $1,126 18 payments
  5. Think Surgical, Inc. $148 1 payment
  6. Sanara MedTech Inc. $144 1 payment
  7. DePuy Synthes Sales Inc. $93 2 payments
  8. Maxx Orthopedics, Inc. $31 1 payment
  9. Goode Surgical Inc $27 1 payment
  10. Orthofix Medical, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Education $4,463 8 payments
  2. Grant $3,000 1 payment
  3. Food and Beverage $2,638 46 payments
  4. Travel and Lodging $1,257 3 payments
Products named General payments · program years 2023–2025
  1. MAKO $2,177 21 payments
  2. Persona $397 3 payments
  3. ROSA $241 3 payments
  4. OSSEOTITE $150 1 payment
  5. TMINI Miniature Robotic System $148 1 payment
  6. CellerateRx $144 1 payment
  7. Velys $78 1 payment
  8. HEALIX KNOTLESS PEEK $78 1 payment
  9. N/A $78 1 payment
  10. VAPR $78 1 payment
  11. Other $450 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

333

Median for Orthopedic Surgery: 203

Drug cost

$2,275

Median for Orthopedic Surgery: $1,433

Branded share of claims

29.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 109 $1,175
Ondansetron Odt Ondansetron Brand 82 $386
Oxycodone Hcl Generic 44 $294
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 16 $149
Pantoprazole Sodium Generic 34 $124
Tramadol Hcl Generic 15 $73
Meloxicam Generic 17 $59
Cefadroxil Generic 16 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$76,832

Of which drugs: $3,819

Medicare patients

228

Average age 76

Services billed

698

147 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 42%
Diabetes 26%
Depression 24%
Atrial fibrillation 23%
Osteoporosis 23%
Chronic kidney disease 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 28 36 $208

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record